AACR Announces Fellows of the AACR Academy Class of 2022
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Patients were matched to therapies targeting specific mutations found in their cancers PHILADELPHIA – Genomic sequencing of tumors from...
PHILADELPHIA, PA and CAMBRIDGE, MA – Two grants for research that could transform cancer detection and treatment have been...
Today, AACR President David A. Tuveson, MD, PhD, FAACR, and AACR Chief Executive Officer Margaret Foti, PhD, MD (hc),...
PHILADELPHIA – T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from...
PHILADELPHIA – A new mutation was identified in 9 percent of relapsed cases of pediatric acute myeloid leukemia (AML)...
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner PHILADELPHIA — The American...
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Raymond N. DuBois, MD, PhD, FAACR, on his...
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) released the AACR Report on the Impact of COVID-19...
WASHINGTON, DC – Today, American Association for Cancer Research (AACR) CEO Margaret Foti, PhD, MD (hc), issued the following...